News | February 12, 2009

Medipattern Launches B-CAD-FOR-LIFE

February 12, 2009 - The Medipattern Corp. said its new sales model for accessing the benefits of B-CAD offers all of the separate components that are required to install, train, use and maintain B-CAD as one package under one monthly service fee.

Medipattern is aiming to effectively manage the service of providing computer-aided detection (CAD) for breast ultrasound imaging for its customers with the B-CAD-FOR-LIFE plan.

"We first spotted B-CAD for the benefits that it could offer our practice early last year, but we are a small business on a tight budget," said Olga Tsireshkin, M.D., founder of XXI Century Radiology and Imaging, P. C. located in Brooklyn, NY. "With B-CAD-FOR-LIFE, Medipattern still owns its asset, B-CAD; installs it, trains our staff in how to use it and maintains it for a monthly fee. This can give XXI Century immediate access to all of the benefits of B-CAD: saving time in documenting each case, improving communication of detailed information, that CAD second opinion, and reimbursement for the procedure in an affordable package. Another important benefit we gain is reporting, before B-CAD we paid a transcription fee for every line on every report, with B-CAD the information is communicated in a concise report - as an automatic part of the procedure. This eliminates transcription fees, reduces human errors, and saves our radiologists the time that they had spent double checking their reports. Our sonographers can make detailed notes electronically now and our radiologists review the Sonographer worksheet plus the CAD information. B-CAD is much more efficient."

For more information: www.medipattern.com

Related Content

Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
SimonMed Deploys ClearRead CT Enterprise Wide
News | Computer-Aided Detection Software | September 17, 2018
September 17, 2018 — National outpatient physician radiology group SimonMed Imaging has selected Riverain Technologie
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
FDA Issues Proposed Order to Reclassify Certain Radiological Medical Image Analyzers
News | Computer-Aided Detection Software | June 01, 2018
The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain radiological medical...
Median Technologies and the Nice University Hospital to Use AI in Lung Cancer Screening
News | Artificial Intelligence | March 15, 2018
March 15, 2018 – Median Technologies, the industry-leading Imaging Phenomics Company and the Nice University Hospital
FDA Clears First AI-Powered Clinical Decision Support Software for Stroke
Technology | Clinical Decision Support | February 14, 2018
The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first ...